(Here comes that) Razors Edge Endovascular stroke therapy: The end, or only the beginning?

International Journal of Stroke

Volumn 8, Issue 5, 2013, Pages 331-333

  Hacke, Werner ^a   Furlan, Antony J ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endovascular; IMS3; IV tPA; PROACT II; Revascularization; Stroke therapy

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; CARDIOVASCULAR PROCEDURE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; ECONOMIC ASPECT; ENDOVASCULAR THERAPY; HEALTH CARE POLICY; HEART ASSIST DEVICE; HUMAN; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; REIMBURSEMENT; REVASCULARIZATION; THROMBECTOMY;

ENDOVASCULAR PROCEDURES; HUMANS; STROKE;

EID: 84879478377     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12103     Document Type: Article

References (12)

1. Hacke W, Zeumer H, Ferbert A etal. Intraarterial thrombolytic therapy improves outcome in patients with acute Vertebrobasilar occlusive disease. Stroke 1988; 19:1216-1222.
2. Furlan AJ, Higashida R, Wechsler L etal. Intra-arterial prourokinase for acute ischemic stroke-the PROACT II study: a randomized controlled trial. JAMA 1992; 282:2003-2011.
3. Higashida RT, Furlan AJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34(8):e109-137.
4. Broderick JP, Palesch YY, Demchuk AM etal. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368:893-903.
5. Kidwell CS, Jahan R, Gornbein J etal. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368:914-923.
6. Ciccone C, Valvassor LJ, Nichelatti M etal. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368:924-932.
7. Chimowitz MI. Endovascular treatment for acute ischemic stroke - still unproven. N Engl J Med 2013; 368:952-955.
8. Saver JL, Reza J, Levy EI etal. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380:1231-1240.
9. Nogueira RG, Jovin TG, Albers GW etal. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380:1241-1249.
10. Lansberg MG, Straka M, Kemp S etal. for the DEFUSE 2 study investigators. *MRI profi le and response to endovascular reperfusion afterstroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012; 11:860-867.
11. Hacke W, Furlan AJ, Al-Rawi Y etal. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8:141-150.
12. Davis SM, Donnan GA, Parsons MW etal. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2009; 7:299-309.